170511 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for hormones
Sub-classes:SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#2BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER
#3HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION
#4HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION
#5Measurement, Diagnosis, Treatment and Management of Metabolic Syndrome
#6Somatostatin Receptor
#7VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOF
#8SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#9Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#10PROTEINS TARGETING ORTHOLOGS
#11RAPID POLYMERIZATION OF POLYPHENOLS
#12SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS
#13Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#14hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject
#15Chemical sensor and method for detecting target substance
#16Compositions and methods for enhancing neuro-repair
#17Method of Identifying Transmembrane Protein-interacting Compounds
#18SRM/MRM Assays For CD56 And CHGA Proteins
#19Highly sensitive and specific luciferase based reporter assay for antigen detection
#20METHODS AND ASSAYS FOR TREATING SUBJECTS WITH SHANK3 DELETION, MUTATION OR REDUCED EXPRESSION
#21System for detecting infection in synovial fluid
#22Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
#23Method for detecting neutralizing antibodies against recombinant human insulin in human serum
#24Method of Identifying Transmembrane Protein-interacting Compounds
#25Proteins targeting orthologs
#26Method of Identifying Transmembrane Protein-interacting Compounds
#27hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject
#28Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#29Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins and uses thereof
#30Antibodies, antibody drug conjugates and methods of use
#31Insulin-like growth factor 1 receptor-specific antibodies and uses thereof
#32Insulin-like growth factor 1 receptor-specific antibodies and uses thereof
#33Insulin-like growth factor 1 receptor-specific antibodies and uses thereof
#34Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#35Marker of cell death
#36Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody
#37SRM/MRM assay for the insulin receptor protein
#38NOVEL BIOMARKERS
#39Biomarkers and methods for measuring and monitoring inflammatory disease activity
#40Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II
#41Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
#42METHOD FOR DIAGNOSIS AND TREATMENT OF PROLACTIN ASSOCIATED DISORDERS
#43SRM/MRM assay for the insulin receptor protein
#44Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
#45Method of identifying transmembrane protein-interacting compounds
#46Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#47Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
#48Methods and assays for treating subjects with SHANK3 deletion, mutation or reduced expression
#49DIFFERENTIATING CARDIAC- AND DIABETES MELLITUS-BASED CAUSES OF KIDNEY DAMAGE
#50BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS
#51Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof
#52PRLR-specific antibody and uses thereof
#53Biomarkers and methods for measuring and monitoring inflammatory disease activity
#54Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer
#55Ligands for the GLP-1 receptor and methods for discovery thereof
#56METHODS FOR MEASURING THE INSULIN RECEPTOR ALPHA SUBUNIT
#57METHODS OF SCREENING COMPOUNDS FOR INSECT-CONTROL ACTIVITY INVOLVING THE TYRAMINE RECEPTOR
#58Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient
#59Method of identifying transmembrane protein-interacting compounds
#60Immunological Method, Test Kit and Device for the Determination of the Analyte Content of a Sample
#61Compositions and methods for visualizing and eliminating cancer stem cells
#62Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease
#63Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody
#64IDENTIFYING DUCT CANCERS
#65Molecules and methods for treatment and detection of cancer
#66Method of treating depression
#67TESTS TO PREDICT RESPONSIVENESS OF CANCER PATIENTS TO CHEMOTHERAPY TREATMENT OPTIONS
#68IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
#69Sour/Acid Taste Receptors Assays, Genes and Proteins
#70Method of identifying transmembrane protein-interacting compounds
#71Methods and Compositions for Measuring Canine BNP and Uses Thereof
#72Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight
#73Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
#74PRLR-specific antibody and uses thereof
#75Methods for identifying modulators of protein kinase C-epsilon (PKC) and method of treatment of aberrant glucose metabolism associated therewith
#76Compositions and Methods For Determining and Predicting Treatment Responses For Depression and Anxiety
#77Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)
#78Growth hormone receptor antagonist cancer treatment
#79Agents for Regulating Adiponectin Receptor Expression
#80Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
#81PTH receptor and screening assay utilizing the same
#82Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
#83Method of identifying responders to treatment with insulin sensitizers
#84Mehod of pretreating sample and immunological assay method using the same
#85Mammalian sour/acid taste and CSF receptor genes, polypeptides and assays
#86Methods for measuring the insulin receptor α subunit
#87Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1)
#88Mammalian obestatin receptors
#89Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain
#90Novel use of edg receptors
#91Mechanism for identifying drugs for the treatment of type II diabetes
#92Compositions and methods for controlling insects involving the tyramine receptor
#93Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
#94Screening methods
#95Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
#96Minrs as modifiers of insulin receptor signaling and methods of use
#97Screening method and anti-tumor drug candidate obtained therefrom
#98Methods and compositions for measuring canine BNP and uses thereof
#99Method of identifying transmembrane protein-interacting compounds
#100Plant cells having receptor polypeptides
#101Biomarker for efficacy of appetite suppressant drugs
#102Guanosine triphosphate (GTP) binding protein-coupled receptor proteins
#103Methods of modulating drug clearance mechanisms by altering SXR activity
#104Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity